Document is current
Any future updates will be listed below
-
Authors
Goñi-Sarriés, Adriana https://orcid.org/0000-0003-2624-3724
Galbete, Arkaitz https://orcid.org/0000-0001-5622-5418
Díez-Suárez, Azucena https://orcid.org/0000-0002-1531-9351
Yárnoz-Goñi, Nora https://orcid.org/0000-0002-9047-2049
Morata-Sampaio, Leticia https://orcid.org/0000-0003-2177-9001
González-Pinto, Ana https://orcid.org/0000-0002-2568-5179
Sánchez-Villegas, Almudena https://orcid.org/0000-0001-7733-9238
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI20/00133; PI24/00028)
- License Information
-
More Information
Article History
Received: 3 February 2025
Accepted: 5 October 2025
First Online: 22 December 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Research Ethics Committees from each recruitment center (Hospital Dr. Negrín de Canarias, PI_2019-478-1; the Department of Health of the Government of Navarra, PI_2020-132; and the Basque Government’s Osakidetza, PI_2021-124.
: Written informed consent was obtained from all participating adolescents, and written informed consent was obtained from their parents through the schools involved in the study.
: The authors have no relevant financial or non-financial interests to disclose.
: AGP has received grants and served as a consultant, advisor, or CME speaker for the following entities: Janssen-Cilag, Lundbeck, Otsuka, Alter, Angelini, Novartis, Rovi, Takeda, the Spanish Ministry of Science and Innovation (CIBERSAM), the Ministry of Science (Carlos III Institute), the Basque Government, and the European Framework Program of Research. The rest of the co-authors declare no competing interests.
